2026 is the year AI governance in healthcare stops being optional.
.png)
A recent Censinet piece nails why healthcare AI governance is the compliance story of 2026: https://censinet.com/perspectives/2026-defining-year-ai-governance-healthcare
2026 is the year AI governance in healthcare stops being optional. I see three forces hitting at once: new federal and state rules, more use of AI in care and payment decisions, and higher risk from vendors, audits, and patient harm.
If I had to sum up the article in plain English, it’s this:
A few numbers show why this matters:
---
Three points worth taking seriously if you're building or buying AI in a regulated shop:
1. Oversight has moved from policy to proof. Agencies stopped accepting broad promises and internal policy documents. They want documented oversight tied to care, payment, and records.
2. "Human in the loop" is now an auditable artifact, not a value statement. Operator competencies, override capabilities, intervention logs, drift monitoring. Not a line in a slide deck.
3. "Human makes the final call" is codified, not aspirational. FDA guidance limits opaque clinical decision support. CMS rules require a clinician, not AI alone, to sign off on coverage.
I am building something that assumes exactly this at Talamel: a 5-tier AI execution maturity model. Fully human-owned decisions on one end, bounded and reversible AI-autonomous tasks on the other, supervised tiers in between. Most teams skip the step where they decide how much oversight a given task actually needs, and just apply one trust level to everything. In a regulated environment that gets you one of two outcomes: you block useful work, or you ship something that never should have gone out unsupervised.
The Censinet piece is the regulatory argument for why that structure has to exist. Not a nice-to-have. A requirement dressed up as a strategy question.
Please sign in to leave a comment.
No comments yet. Be the first to comment!